tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
LEXX
Lexaria Bioscience
RESEARCH TOOLSreports

Lexaria Bioscience (LEXX) Stock News & Sentiment

242 Followers
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
Premium
Company Announcements
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
3d ago
LEXX
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
Premium
Company Announcements
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
9d ago
LEXX
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
Premium
Company Announcements
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
15d ago
LEXX
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
Premium
Company Announcements
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
17d ago
LEXX
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
Premium
Company Announcements
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
1M ago
LEXX
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
Premium
Company Announcements
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
2M ago
LEXX
Lexaria Bioscience Shareholders Endorse Directors and Auditors
Premium
Company Announcements
Lexaria Bioscience Shareholders Endorse Directors and Auditors
2M ago
8K
LEXX
More LEXX News >

LEXX News on the Web

Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
TipRanks News
Bullish
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
TipRanks News
Bullish
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
TipRanks News
Bullish
Lexaria Bioscience to begin new human clinical study in GLP-1
TipRanks News
Bullish
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
TipRanks News
Bullish
Lexaria receives five new patents, including two for diabetes treatment
TipRanks News
Bullish
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
TipRanks News
Bullish
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
TipRanks News
Neutral

News Score - Last 7 Days

Positive
LEXX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LEXX’s Media Buzz Sentiment?
2 articles about LEXX were published this week. In an average week, 1.75 articles are published.
    What is LEXX’s weekly average amount of articles?
    In an average week, 1.75 articles about LEXX are published.
      What is LEXX’s News Sentiment?
      100% of articles about LEXX were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week